Ptc Therapeutics (PTCT) Treasury Shares (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Treasury Shares of $3.5 million for Q2 2026, down 7.76% year-over-year from $3.8 million in Q2 2025, and down 2.56% quarter-over-quarter from $3.6 million in Q1 2026.
Ptc Therapeutics (PTCT) Treasury Shares (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Treasury Shares history runs 15 years deep, the most recent figure standing at $3.5 million for Q2 2026.
- In Q2 2026, Treasury Shares fell 7.76% year-over-year to $3.5 million; the TTM figure through Jun 2026 stood at $3.5 million (down 7.76% YoY), while the FY2025 annual figure was $3.7 million, up 3.96% from the prior year.
- Treasury Shares for Q2 2026 stood at $3.5 million, down from $3.6 million in the prior quarter.
- The five-year high for Treasury Shares was $3.9 million in Q1 2025, with the low at $2.5 million in Q3 2022.
- The 5-year median for Treasury Shares is $3.6 million (2024), against an average of $3.4 million.
- The sharpest annual moves came in 2022 and 2026: Treasury Shares soared 68.27% in 2022, then decreased 7.76% in 2026.
- Ptc Therapeutics' Treasury Shares stood at $2.5 million in 2022, then advanced by 13.91% to $2.9 million in 2023, then gained by 23.07% to $3.5 million in 2024, then gained by 3.96% to $3.7 million in 2025, then declined by 3.95% to $3.5 million in 2026.
- Business Quant data shows PTCT's Treasury Shares at $3.5 million in Q2 2026, $3.6 million in Q1 2026, and $3.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 3.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.52 Mn |
| Jun 30, 2026 | 3.52 Mn |
| Mar 31, 2026 | 3.62 Mn |
| Mar 31, 2026 | 3.62 Mn |
| Dec 31, 2025 | 25,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 3.79 Mn |
| Sep 30, 2025 | 3.79 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Mar 31, 2025 | 3.87 Mn |
| Dec 31, 2024 | 206,250.00 |
| Dec 31, 2024 | 206,250.00 |
| Sep 30, 2024 | 3.60 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 3.60 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.73 Mn |